LPL Financial’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.73M Buy
29,670
+13,355
+82% +$1.68M ﹤0.01% 2539
2025
Q1
$1.8M Sell
16,315
-439
-3% -$48.6K ﹤0.01% 3017
2024
Q4
$2.29M Buy
16,754
+3,643
+28% +$497K ﹤0.01% 2726
2024
Q3
$1.51M Buy
13,111
+783
+6% +$90.2K ﹤0.01% 2965
2024
Q2
$1.7M Sell
12,328
-232
-2% -$31.9K ﹤0.01% 2732
2024
Q1
$1.73M Buy
12,560
+2,733
+28% +$377K ﹤0.01% 2639
2023
Q4
$1.29M Buy
9,827
+13
+0.1% +$1.71K ﹤0.01% 2802
2023
Q3
$1.1M Buy
9,814
+1,600
+19% +$180K ﹤0.01% 2792
2023
Q2
$775K Buy
8,214
+21
+0.3% +$1.98K ﹤0.01% 3049
2023
Q1
$829K Sell
8,193
-3,016
-27% -$305K ﹤0.01% 2888
2022
Q4
$1.34M Sell
11,209
-4,278
-28% -$511K ﹤0.01% 2409
2022
Q3
$1.65M Sell
15,487
-1,481
-9% -$157K ﹤0.01% 2133
2022
Q2
$1.65M Sell
16,968
-1,157
-6% -$113K ﹤0.01% 2169
2022
Q1
$1.7M Sell
18,125
-1,298
-7% -$122K ﹤0.01% 2181
2021
Q4
$1.65M Sell
19,423
-1,384
-7% -$118K ﹤0.01% 2225
2021
Q3
$2M Buy
20,807
+6,644
+47% +$637K ﹤0.01% 2038
2021
Q2
$1.38M Buy
14,163
+7,654
+118% +$745K ﹤0.01% 2291
2021
Q1
$633K Sell
6,509
-2,035
-24% -$198K ﹤0.01% 2814
2020
Q4
$819K Buy
8,544
+690
+9% +$66.1K ﹤0.01% 2338
2020
Q3
$755K Buy
7,854
+1,670
+27% +$161K ﹤0.01% 2138
2020
Q2
$754K Buy
6,184
+386
+7% +$47.1K ﹤0.01% 2045
2020
Q1
$502K Sell
5,798
-201
-3% -$17.4K ﹤0.01% 2098
2019
Q4
$645K Buy
5,999
+2,614
+77% +$281K ﹤0.01% 2154
2019
Q3
$305K Sell
3,385
-217
-6% -$19.6K ﹤0.01% 2655
2019
Q2
$304K Sell
3,602
-949
-21% -$80.1K ﹤0.01% 2679
2019
Q1
$401K Buy
4,551
+657
+17% +$57.9K ﹤0.01% 2392
2018
Q4
$278K Buy
+3,894
New +$278K ﹤0.01% 2512
2013
Q4
Sell
-19,699
Closed -$202K 2676
2013
Q3
$202K Buy
+19,699
New +$202K ﹤0.01% 2316